Terms: = Bone cancer AND CEACAM5, CEA AND Prognosis
69 results:
1. [Clinical characteristics and prognosis analysis of 17 cases of SMARCA4-deficient chest tumors].
Cao XN; Li Z; Wang QY
Zhonghua Jie He He Hu Xi Za Zhi; 2024 Apr; 47(4):325-331. PubMed ID: 38599807
[No Abstract] [Full Text] [Related]
2. Serum IGFBP-1 as a promising diagnostic and prognostic biomarker for colorectal cancer.
Huang BL; Wei LF; Lin YW; Huang LS; Qu QQ; Li XH; Chu LY; Xu YW; Wang WD; Peng YH; Wu FC
Sci Rep; 2024 Jan; 14(1):1839. PubMed ID: 38246959
[TBL] [Abstract] [Full Text] [Related]
3. Pretreatment controlling nutritional status (CONUT) score and carcinoembryonic antigen level provide tumor progression and prognostic information in gastric cancer: A retrospective study.
Chen X; Chen C; Huang L; Wu P
Medicine (Baltimore); 2023 Dec; 102(49):e36535. PubMed ID: 38065858
[TBL] [Abstract] [Full Text] [Related]
4. Preoperative predictors for recurrence sites associated with poor post-recurrence survival after surgery of non-small cell lung cancer: a multicenter study.
Isaka T; Adachi H; Murakami K; Miura J; Kikunishi N; Shigeta N; Kudo Y; Miyata Y; Okada M; Ikeda N; Ito H
BMC Cancer; 2023 Nov; 23(1):1064. PubMed ID: 37926846
[TBL] [Abstract] [Full Text] [Related]
5. Prognostic impact of tumor size on patients with metastatic colorectal cancer: a large SEER-based retrospective cohort study.
Zhang Q; Li B; Zhang S; Huang Q; Zhang M; Liu G
Updates Surg; 2023 Aug; 75(5):1135-1147. PubMed ID: 37202599
[TBL] [Abstract] [Full Text] [Related]
6. Systematic review of isolated disseminated carcinomatosis of bone marrow from colorectal cancer.
Chan WK; Lin NS; Tay KV; Teo LT
ANZ J Surg; 2023 May; 93(5):1169-1175. PubMed ID: 36772885
[TBL] [Abstract] [Full Text] [Related]
7. Homogeneous and heterogeneous risk and prognostic factors for lung metastasis in colorectal cancer patients.
Wang H; Shan X; Zhang M; Qian K; Shen Z; Zhou W
BMC Gastroenterol; 2022 Apr; 22(1):193. PubMed ID: 35436849
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic Factors of bone Metastases From Colorectal cancer in the Era of Targeted Therapy.
Kobayashi Y; Shida D; Boku N; Yasui K; Nakamura Y; Kudose Y; Imaizumi J; Kanemitsu Y
Dis Colon Rectum; 2023 Mar; 66(3):401-409. PubMed ID: 35239524
[TBL] [Abstract] [Full Text] [Related]
9. Immune Dysfunction as Measured by the Systemic Immune-Inflammation Index is Associated with the Sub-Type of Minimal Residual Disease and Outcome in Stage II Colon cancer Treated with Surgery alone.
Murray NP; Villalon R; Orrego S; Guzman E
Asian Pac J Cancer Prev; 2021 Aug; 22(8):2391-2397. PubMed ID: 34452551
[TBL] [Abstract] [Full Text] [Related]
10. Lorlatinib Induces Durable Disease Stabilization in a Pancreatic cancer Patient with a ROS1 p.L1950F Mutation: Case Report.
Velthaus JL; Iglauer P; Simon R; Bokemeyer C; Bannas P; Beumer N; Imbusch CD; Goekkurt E; Loges S
Oncol Res Treat; 2021; 44(9):495-502. PubMed ID: 34320493
[TBL] [Abstract] [Full Text] [Related]
11. Effect of osimertinib in treating patients with first-generation EGFR-TKI-resistant advanced non-small cell lung cancer and prognostic analysis.
Yang Y; Guo Y; Wang R; Li J; Zhu H; Guo RTW
J BUON; 2021; 26(1):51-57. PubMed ID: 33721431
[TBL] [Abstract] [Full Text] [Related]
12. Nomogram for predicting overall survival in colorectal cancer with distant metastasis.
Liu Z; Xu Y; Xu G; Baklaushev VP; Chekhonin VP; Peltzer K; Ma W; Wang X; Wang G; Zhang C
BMC Gastroenterol; 2021 Mar; 21(1):103. PubMed ID: 33663400
[TBL] [Abstract] [Full Text] [Related]
13. Lenvatinib as a salvage therapy for advanced metastatic medullary thyroid cancer.
Matrone A; Prete A; Nervo A; Ragni A; Agate L; Molinaro E; Giani C; Valerio L; Minaldi E; Piovesan A; Elisei R
J Endocrinol Invest; 2021 Oct; 44(10):2139-2151. PubMed ID: 33594641
[TBL] [Abstract] [Full Text] [Related]
14. Survival outcome and prognostic factors for colorectal cancer with synchronous bone metastasis: a population-based study.
Li X; Hu W; Sun H; Gou H
Clin Exp Metastasis; 2021 Feb; 38(1):89-95. PubMed ID: 33420873
[TBL] [Abstract] [Full Text] [Related]
15. Individualized prediction of survival benefit from primary tumor resection for patients with unresectable metastatic colorectal cancer.
Yang Y; Lu Y; Jiang W; Zhu J; Yan S
World J Surg Oncol; 2020 Aug; 18(1):193. PubMed ID: 32746835
[TBL] [Abstract] [Full Text] [Related]
16. Serum cea and CYFRA Levels in ALK-rearranged NSCLC Patients: Correlation With Distant Metastasis.
Numata T; Endo T; Yanai H; Ota K; Yamamoto Y; Shimizu K; Yamada H; Hayashihara K; Okauchi S; Satoh H; Yamada Y; Tamura T; Saito K; Kikuchi N; Kurishima K; Ishikawa H; Watanabe H; Shiozawa T; Hizawa N; Funayama Y; Hayashi S; Nakamura H; Yamashita T
In Vivo; 2020; 34(4):2095-2100. PubMed ID: 32606188
[TBL] [Abstract] [Full Text] [Related]
17. Nomogram to predict the risk and survival of synchronous bone metastasis in colorectal cancer: a population-based real-world analysis.
Han L; Dai W; Mo S; Xiang W; Li Q; Xu Y; Wang R; Cai G
Int J Colorectal Dis; 2020 Aug; 35(8):1575-1585. PubMed ID: 32417937
[TBL] [Abstract] [Full Text] [Related]
18. Association Between Baseline Circulating Tumor Cells, Molecular Tumor Profiling, and Clinical Characteristics in a Large Cohort of Chemo-naïve Metastatic Colorectal cancer Patients Prospectively Collected.
Sastre J; Orden V; Martínez A; Bando I; Balbín M; Bellosillo B; Palanca S; Peligros Gomez MI; Mediero B; Llovet P; Moral VM; Viéitez JM; García-Alfonso P; Calle SG; Ortiz-Morales MJ; Salud A; Quintero G; Lopez C; Díaz-Rubio E; Aranda E;
Clin Colorectal Cancer; 2020 Sep; 19(3):e110-e116. PubMed ID: 32278676
[TBL] [Abstract] [Full Text] [Related]
19. Metastatic patterns and survival outcomes in patients with stage IV colon cancer: A population-based analysis.
Wang J; Li S; Liu Y; Zhang C; Li H; Lai B
Cancer Med; 2020 Jan; 9(1):361-373. PubMed ID: 31693304
[TBL] [Abstract] [Full Text] [Related]
20. Lung Metastasis Predicts Better prognosis in Metastatic Colorectal cancer With Mutated KRAS.
Margalit O; Shacham-Shmueli E; Lawrence YR; Yang YX; Reiss KA; Golan T; Mamtani R; Halpern N; Aderka D; Giantonio B; Boursi B
Clin Colorectal Cancer; 2019 Sep; 18(3):e300-e307. PubMed ID: 31324478
[TBL] [Abstract] [Full Text] [Related]
[Next]
